• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 151
  • 111
  • 40
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • Tagged with
  • 278
  • 278
  • 156
  • 156
  • 128
  • 69
  • 36
  • 29
  • 28
  • 27
  • 27
  • 26
  • 26
  • 24
  • 24
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
151

In vivo imaging of retinal ganglion cells and microglia. / CUHK electronic theses & dissertations collection

January 2010 (has links)
A confocal scanning laser ophthalmoscope (CSLO) was used to image the axonal and dendritic aborizations of RGCs in the Thy-1 YFP mice. With quantitative analysis of cell body area, axon diameter, dendritic field, number of terminal branches, total dendritic branch length, branching complexity, symmetry and distance from the optic disc, the morphologies of RGCs and the patterns of axonal and dendritic degeneration were analyzed. After optic nerve crush, RGC damage was observed prospectively to begin with progressive dendritic shrinkage, followed by loss of the axon and the cell body. Similar pattern of RGC degeneration was observed after 90 minutes of retinal ischemia although no morphological changes were detected when the duration of ischemia was shortened to 30 minutes. The rate of dendritic shrinkage was variable and estimated on average 2.0% per day and 11.7% per day with linear mixed modeling, after optic nerve crush and retinal ischemic injury, respectively. RGCs with a larger dendritic field had a slower rate of dendritic shrinkage. / In summary, we demonstrated that dendritic shrinkage could be evident even before axonal degeneration after optic nerve crush and retinal ischemic injury. We have established a methodology for in vivo and direct visualization of RGCs and retinal microglia, which could provide reliable and early markers for neuronal damage. Measuring the rate of dendritic shrinkage and tracking the longitudinal activation of microglia would provide new paradigms to study the mechanism of neurodegenerative diseases and offer new insights in testing novel therapies for neuroprotection. / Progressive neuronal cell death and microglial activation are the key pathological features in most neurodegenerative diseases. While investigating the longitudinal profiles of neuronal degeneration and microglial activation is pertinent to understanding disease mechanism and developing treatment, analyzing progressive changes has been obfuscated by the lack of a non-invasive approach that allows long term, serial monitoring of individual neuronal and microglial cells. Because of the clear optical media in the eye, direct visualization of the retinal ganglion cells (RGCs) and microglia is possible with high resolution in vivo imaging technique. In this study, we developed experimental models to visualize and characterize the cellular morphology of RGCs and retinal microglia in vivo in the Thy-1 YFP and the CX3CR1 +/GFP transgenic mice, described the patterns of axonal and dendritic shrinkage of RGCs, discerned the dynamic profile of microglial activation and investigated the relationship between RGC survival and microglial activation after optic nerve crush and retinal ischemic injury induced by acute elevation of intraocular pressure. / The longitudinal profile of microglial activation was investigated by imaging the CX3CR1GFP/+ transgenic mice with the CSLO. Activation of retinal microglia was characterized with an increase in cell number reaching a peak at a week after optic nerve crush and retinal ischemic injury, which was followed by a gradual decline falling near to the baseline at the 4 th week. The activation of retinal microglia was proportional to the severity of injury. The number of RGCs survival at 4 weeks post-injury was significantly associated with the number of activated retinal microglia. / Li, Zhiwei. / Adviser: Leung Kai Shun. / Source: Dissertation Abstracts International, Volume: 73-02, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 50-66). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
152

Baicalin-mediated neuronal induction of neural stem cells and improvement of cognitive function in a mouse stroke model. / CUHK electronic theses & dissertations collection

January 2009 (has links)
Baicalin, which is a flavonoid, was previously shown to exert neuroprotective effects against ischemic injury and oxidative insults. In this study, baicalin was found to induce neuronal differentiation on both C17.2 NSC and primary mouse NSC originated from hippocampuses of E14.5 mouse embryos. The baicalin-mediated differentiation of C17.2 NSC was noted in dose- and time-dependent manners. Baicalin-treated NSC displayed long processes of neurites. The gene expression of neuronal markers, NF-L, TUBB3 and MAP2 was also significantly increased after treated with 20 to 50 muM baicalin on C17.2 NSC. Treating C17.2 NSC with baicalin significantly increased the number of TUBB3 positive cells by 300%. A significant increase in the gene expression of TUBB3 was also observed on primary NSC upon baicalin treatment at 5 to 10 muM. The number of TUBB3 positive cells was increased by 100% after treating with 10 muM baicalin. C17.2 NSC treated with baicalin also increased the gene expression of GABAergic and serotonergic neuronal subtype specific enzymes GAD1 and TPH1. / Nature provides a vast pool of natural compounds with neuroprotection and neurotrophism. A few of these compounds can induce the differentiation of neural stem cells (NSC). There are ample opportunities to discover more natural compounds with differentiation inducing effect on NSC. One of the objectives of this project is to look for novel natural compounds showing neurogenic effect on NSC. This project has established a platform for screening medicinal materials and natural compounds with neural differentiation promoting effect on C17.2 mouse neural stem cell line. Screening results identified total Sanqi saponins, total Renshen saponins, Huangqin extracts and baicalin as potent candidates for inducing this differentiation of NSC. / This project also aims at characterizing the mechanisms involved in the neuronal differentiation effect of baicalin on NSC. Annotation from microarray analysis indicated that baicalin treatment on C17.2 NSC is related to development of tissue and nervous system. qPCR study attested the increased gene expression of nerve growth factor-beta, neurotrophin-3, pro-neural transcriptional factors Ngn1, Ngn2 and NeuroD2. Western blotting showed that baicalin activated ERK1/2 MAP kinase but not JNK and p38 MAP kinases. / This project demonstrated the neurogenic potential of natural resources on NSC. A novel neuronal induction effect of baicalin on NSC was also demonstrated with its mechanisms characterized. This project also revealed that baicalin can be used for promoting functional recovery of post-ischemia animals. / This study showed for the first time that baicalin exerts neuronal differentiation inducing effect on NSC. Another objective of this project is to study whether baicalin can promote functional recovery of animals with ischemia brain injury. Mice having undergone transient occlusion of the bilateral common carotid arteries with blood-reperfusion to induce global cerebral ischemia were treated with baicalin and/or EGFP-NSC. Ischemia animals received implantation of EGFP-NSC into the caudate putamen and/or intravenous injection of baicalin on alternate days for two-week on day seven post-ischemia displayed significant improvement of the cognitive function in terms of the incident of error and escape time in the water T-maze task compared to the control arm of ischemia mice. Data of the study suggested that the therapeutic effect of baicalin would be comparable to that of neural stem cell transplant in improving the cognitive function in a mouse ischemic stroke model. / Li, Ming. / Adviser: P. C. Shaw. / Source: Dissertation Abstracts International, Volume: 73-01, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaves 199-232). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
153

Histone post-translational modifications in the brain of the senescence-accelerated prone 8 mouse. / CUHK electronic theses & dissertations collection

January 2009 (has links)
In this study, the brain of senescence accelerated mouse prone 8 (SAMP8) mice model was adopted to investigate PTMs state (especially methylation patterns) of core histones (H2A, H2B, H3 and H4). Seven methylated sites (H3K24, H3K27, H3K36, H3K79, H3R128, H4K20 and H2A R89) were detected by tandem matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/TOF MS) analysis. The methylation of H3K27 and H3K36 demonstrated a modulating relationship and methylated H3K27 might contribute to the hypermethylation state and gene repression in aged brain. Western blotting results showed that mono-methylated H4K20 decreased during SAMP8 mice aging and di-methylated H3K79 decreased in the brain of 12-month-old SAMP8 mice compared with age-matched senescence accelerated-resistant mouse (SAMR1) control. Di-methylated H3K79 could express in neuron cells of cerebral cortex and hippocampus. Whereas, the number of H3K79 methylation negative cells was higher in the cortex of 12-month old SAMP8 mice than that of age-matched control SAMR1 mice. Chromatin immunoprecipitation (ChIP) result indicated homeodomain transcription factor Pbx1 isoform 1 (Pbx1), transcription factors and transcriptional regulator proteins, such as T-box isoform 20, TetR family precursor BAZ2B and ribosomal protein, were recruited to methylated H3K79 site. Therefore, a model of methylated H3K79 on gene transcriptional regulation was proposed. Furthermore, the consequences of decreased H3K79 methylation in Neuro-2a (N2a) cells were investigated via transfection with Dot1 (disruptor of telomeric silencing) siRNA. After transfection, N2a cells displayed shorter neurite and less dendrite. Proteomic change in the N2a cells provided convincing evidence for the multi-function of decreased H3K79 methylation on transcriptional regulation, protein translation and folding, stress response and DNA breaks repair, which would contribute to brain dysfunction during neurodegenerative disease or aging. / Nowadays, many countries including China are experiencing aging populations. Aging has become the major risk factor for many diseases, such as neurodegenerative disease. The studies on the role of epigenetics in the aging process have grown tremendously in recent years. However, no systematic investigations have provided the information on histone post-translational modifications (PTMs) in aged brain and the roles of histone PTMs in brain aging are still unknown. / This study gave a new insight into the link between histone PTMs and brain aging. It could provide the experimental evidence for future studies and help us to better understand aging or neurodegenerative disease at epigenetic level. Furthermore, it could benefit for setting up the strategies for epigenetic therapy to neurodegenerative disease. / Wang, Chunmei. / Adviser: Ngai Saiming. / Source: Dissertation Abstracts International, Volume: 73-01, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2009. / Includes bibliographical references (leaf 136). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
154

Development of a canine flow probe model to investigate aspects of cardiac monitors and vasopressor therapies that can not be tested clinically. / CUHK electronic theses & dissertations collection

January 2004 (has links)
Peng Zhiyong. / "December 2004." / Thesis (Ph.D.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (p. 146-175) / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Mode of access: World Wide Web. / Abstracts in English and Chinese.
155

Investigations of factors that control retinal axon growth during mouse optic pathway development. / CUHK electronic theses & dissertations collection

January 2010 (has links)
Chiasm cells, which include glia and neurons, are generated early before any retinal axon arrives at the midline of the mouse ventral diencephalon. These cells have been shown to affect retinal axon growth and patterning in the optic chiasm. In this study, we used EdU (5-ethyny1-2'-deoxyuridine) for birthdating these chiasm cells, aiming to find out when these cells are generated; then we tried to trace their fates at later stages of development. EdU injection at embryonic day (E) 9.5 to El 1 labeled a number of chiasmatic neurons and radial glial cells at E13, which were immunoreactive for SSEA-1 and RC2, respectively. After colocalization studies, we found that most of these neurons were born as early as E9.5, while a large number of radial glial cells were born as from El 1. Both E9.5-born chiasmatic neurons and Ell-born radial glia decreased by E14-E16; the radial glia even disappeared finally from the midline. Furthermore, we found that some chiasmatic neurons underwent apoptotic cell death as from El 4, and that the radial glia likely differentiated into other cell types after finishing their retinal axon guidance mission at the midline. So it is reasonable that some of the earliest born chiasm cells disappear during development. / During development, retinal ganglion cell axons grow from the eye to the ventral diencephalon, where axons from the two eyes converge and segregate into crossed and uncrossed projections, forming the optic chiasm. This pattern is critical for binocular vision. Although significant progress has been obtained over the past decades, how retinal axon growth and guidance are regulated at the chiasm is largely unknown. Our research will focus on those problems. / In the last part of this thesis, we investigated the retinal axon pathway in the ventral diencephalon of the Sox10Dom mutant embryos and gamma-crystallin mutant embryos. Our findings indicate that Sox10 may not contribute to axon guidance in the developing optic pathway whereas gammaA-crystallin may only play a role in the later uncrossed axons. / N-methyl-D-aspartate (NMDA) receptor is one of the ionotropic glutamate receptors, which are important in synaptic plasticity, apart from implications in dendritic spine remodeling, neurite outgrowth, elongation and branching and glutamate neurotoxicity. There are several subtypes of NMDA receptor channel subunits, NR1, NR2A-D, NR3A&B. The functional diversity of NMDA receptor resides in the different assembly of subunits. In this study, we used RT-PCR to analyze the mRNA expression of all the NMDA receptor subunits in mouse embryos. After that we chose the NR1, NR2B and NR3A antibodies to investigate NMDA receptor subunit expression in the optic pathway during mouse optic pathway development. Using immunohistochemistry, we found that NR1, NR2B and NR3A were expressed in the mouse retina and optic pathway as from E13 when the optic chiasm is forming. Expression of the NMDA receptor subunits were found in the inner cell layers and along retinal axons. Colocalization studies showed that NR1, NR2B and NR3A were localized on the ganglion cells and their axons. In the ventral diencephalon, these subunits were expressed extensively, but NR1 and NR3A were particularly strong along the optic nerve and optic tract. Furthermore, to identify the function of NMDA receptor during optic chiasm development, we cultured E14 retinal explants on laminin and poly-D-ornithine in the presence of the NMDA receptor antagonists MK-801 or Dextrorphan-D-tartrate. These two antagonists can significantly inhibit the retinal axon outgrowth, suggesting that the NMDA receptor promotes retinal axon outgrowth in the retinofugal pathway during optic chiasm development. / Li, Jia. / Adviser: Chan Sun On. / Source: Dissertation Abstracts International, Volume: 73-02, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 145-158). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.
156

Studies of tachykinin receptor agonist and antagonists on adjuvant-induced arthritis in the rat.

January 2001 (has links)
Wong Hei Lui. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2001. / Includes bibliographical references (leaves 192-226). / Abstracts in English and Chinese. / Publications Based On The Work In This Thesis --- p.i / Abstract --- p.ii / Acknowledgements --- p.vii / Abbreviations --- p.viii / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Normal joint --- p.1 / Chapter 1.11 --- Biology of joint --- p.1 / Chapter 1.12 --- Structure of synovial joint --- p.1 / Chapter 1.13 --- Components of the mature synovial joint --- p.3 / Chapter 1.131 --- Articular cartilage --- p.3 / Chapter 1.1311 --- Water --- p.4 / Chapter 1.1312 --- Cartilage matrix --- p.4 / Chapter 1.1313 --- Chondrocyte --- p.5 / Chapter 1.132 --- Synovium --- p.5 / Chapter 1.1321 --- Synovium vasculature --- p.6 / Chapter 1.1322 --- Synovial blood flow --- p.7 / Chapter 1.133 --- Synovial fluid --- p.8 / Chapter 1.134 --- Bone --- p.9 / Chapter 1.2 --- Pathological processes of arthritis --- p.11 / Chapter 1.21 --- Activation of immune cells in arthritis --- p.11 / Chapter 1.22 --- Synovial proliferation --- p.13 / Chapter 1.221 --- Synovial lining cell activation --- p.13 / Chapter 1.222 --- Pannus invasion --- p.14 / Chapter 1.23 --- Cartilage and bone degradation --- p.14 / Chapter 1.231 --- Depletion of proteoglycan (GAG) --- p.15 / Chapter 1.232 --- Collagen denature --- p.15 / Chapter 1.3 --- Tachykinins (TKs) --- p.17 / Chapter 1.31 --- History --- p.17 / Chapter 1.32 --- "Synthesis, storage and release of TKs" --- p.17 / Chapter 1.33 --- Tachykinin receptors --- p.18 / Chapter 1.331 --- Characterization of NK1 receptor --- p.19 / Chapter 1.332 --- Characterization of NK2 receptor --- p.19 / Chapter 1.333 --- Characterization of NK3 receptor --- p.20 / Chapter 1.34 --- Effector systems of TKs --- p.21 / Chapter 1.35 --- Termination of TK signals --- p.21 / Chapter 1.351 --- Enzymatic breakdown --- p.21 / Chapter 1.352 --- Receptor desensitization --- p.22 / Chapter 1.353 --- Receptor endocytosis --- p.22 / Chapter 1.36 --- TK receptor antagonists --- p.23 / Chapter 1.361 --- Selective NK1 receptor antagonists --- p.23 / Chapter 1.362 --- Selective NK2 receptor antagonists --- p.24 / Chapter 1.363 --- Selective NK3 receptor antagonists --- p.25 / Chapter 1.4 --- Roles of tachykinins in arthritis --- p.28 / Chapter 1.41 --- Correlation between tachykinins and joint inflammation --- p.28 / Chapter 1.42 --- Roles of tachykinins in immune cell activation --- p.30 / Chapter 1.43 --- Roles of tachykinins in synovial proliferation --- p.31 / Chapter 1.44 --- Roles of tachykinins in cartilage degradation --- p.32 / Chapter 1.5 --- Animal model of arthritis --- p.33 / Chapter 1.51 --- Instability model --- p.33 / Chapter 1.52 --- Immobilization model --- p.34 / Chapter 1.53 --- Noxious agent-induced model --- p.34 / Chapter 1.531 --- Collagen-induced erosive arthritis --- p.34 / Chapter 1.532 --- Cartilage oligometric matrix protein-induced arthritis --- p.35 / Chapter 1.533 --- Oil-induced arthritis --- p.35 / Chapter 1.534 --- Streptococcal cell wall-induced arthritis --- p.35 / Chapter 1.535 --- Adjuvant-induced arthritis --- p.36 / Chapter 1.536 --- Pristane-induced arthritis --- p.36 / Chapter 1.6 --- Current anti-arthritic therapies --- p.39 / Chapter 1.61 --- Non steroid anti-inflammatory drugs --- p.39 / Chapter 1.62 --- Glucocorticoid --- p.44 / Chapter 1.63 --- Second-line treatment --- p.46 / Chapter 1.631 --- Sulfasalazine --- p.46 / Chapter 1.632 --- Gold salts --- p.47 / Chapter 1 633 --- D-penicillamine --- p.48 / Chapter 1.634 --- Antimalarial --- p.49 / Chapter 1 .635 --- Methotrexate --- p.51 / Chapter 1.64 --- New trends for treatment of arthritis --- p.53 / Chapter 1.641 --- Anti-cytokine therapy --- p.53 / Chapter 1.642 --- Anti-angiogenesis therapy --- p.54 / Chapter 1.7 --- Aims of study --- p.57 / Chapter Chapter 2 --- Material and drugs --- p.62 / Chapter Chapter 3 --- Methodology --- p.62 / Chapter 3.1 --- Animals used and anaesthetization --- p.62 / Chapter 3.2 --- Measurement of plasma protein extravasation --- p.63 / Chapter 3.3 --- Measurement of knee joint sizes --- p.64 / Chapter 3.4 --- Measurement of knee joint blood flow --- p.65 / Chapter 3.5 --- Measurement of histological changes --- p.65 / Chapter 3.51 --- Dissection and fixation --- p.65 / Chapter 3.52 --- Decalcification --- p.66 / Chapter 3.53 --- Processing --- p.66 / Chapter 3.54 --- Embedding --- p.67 / Chapter 3.55 --- Sectioning --- p.67 / Chapter 3.56 --- Staining --- p.69 / Chapter 3.6 --- Data analysis --- p.69 / Chapter 3.61 --- Scoring systems --- p.72 / Chapter Chapter 4 --- A model of monoarthritis in rats --- p.72 / Chapter 4.1 --- Introduction --- p.72 / Chapter 4.2 --- Method --- p.73 / Chapter 4.3 --- Results --- p.73 / Chapter 4.31 --- Lewis rats --- p.73 / Chapter 4.32 --- Sprague-Dawley (SD) rats --- p.74 / Chapter 4.33 --- Comparison of FCA-induced changes in Lewis and SD rats --- p.74 / Chapter 4.34 --- Histological studies on arthritic SD rats --- p.75 / Chapter 4.4 --- Discussion --- p.93 / Chapter 4.5 --- Conclusions --- p.95 / Chapter Chapter 5 --- Effect of Substance P on adjuvant-induced arthritis --- p.96 / Chapter 5.1 --- Introduction --- p.96 / Chapter 5.2 --- Method --- p.98 / Chapter 5.3 --- Results --- p.99 / Chapter 5.31 --- Evans blue extravasation --- p.99 / Chapter 5.32 --- Joint size --- p.100 / Chapter 5.33 --- Knee joint blood flow --- p.101 / Chapter 5.34 --- Histology results --- p.102 / Chapter 5.341 --- Infiltration of immune cells in synovial tissue --- p.102 / Chapter 5.342 --- Synovial tissue proliferation --- p.102 / Chapter 5.343 --- Cartilage degradation --- p.103 / Chapter 5.344 --- Bone degradation --- p.103 / Chapter 5.4 --- Discussion --- p.120 / Chapter 5.5 --- Conclusions --- p.125 / Chapter Chapter 6 --- Effects of tachykinin receptor antagonists on FCA-induced arthritis / Chapter 6.1 --- Introduction --- p.126 / Chapter 6.2 --- Method --- p.128 / Chapter 6. 21 --- Intravenous NK1 receptor antagonists on FCA-induced arthritis --- p.128 / Chapter 6. 22 --- Intraperitoneal TK receptor antagonists on FCA-induced arthritis --- p.128 / Chapter 6.3 --- Results --- p.129 / Chapter 6.31 --- Intravenous NK1 227}0اreceptor antagonists on FCA-induced arthritis Evans blue extravasation and joint swelling --- p.129 / Chapter 6.32 --- Intraperitoneal tachykinin receptor antagonists on FCA- induced arthritis Evans blue extravasation and joint swelling --- p.129 / Chapter 6.33 --- Intraperitoneal tachykinin receptor antagonists on FCA- induced immune cell accumulation --- p.130 / Chapter 6.34 --- Intraperitoneal tachykinin receptor antagonists on FCA- induced synovial tissue proliferation --- p.131 / Chapter 6.35 --- Intraperitoneal tachykinin receptor antagonists on FCA- induced cartilage degration and bone erosion --- p.131 / Chapter 6.4 --- Discussion --- p.159 / Chapter 6.5 --- Conclusions --- p.162 / Chapter Chapter 7 --- Individual and combined effects of dexamethasone and TK receptor antagonists on FCA-induced arthritis --- p.163 / Chapter 7.1 --- Introduction --- p.163 / Chapter 7.2 --- Method --- p.166 / Chapter 7.3 --- Results --- p.167 / Chapter 7.31 --- Evans blue extravasation --- p.167 / Chapter 7.32 --- Knee joint size --- p.167 / Chapter 7.33 --- Body weight --- p.168 / Chapter 7.34 --- Cellular infiltration --- p.168 / Chapter 7.35 --- Synovial tissue proliferation --- p.168 / Chapter 7.36 --- Cartilage degradation --- p.169 / Chapter 7.4 --- Discussion --- p.184 / Chapter 7.5 --- Conclusions --- p.187 / Chapter Chapter 8 --- General discussions and conclusions --- p.188 / References --- p.192
157

Impairment of calcitonin gene-related peptide (CGRP)-induced hypotensive responses in vivo and vasorelaxant responses in vitro in rat models of aging, diabetes mellitus and ovariectomy.

January 2001 (has links)
Chan Hoi-Huen. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2001. / Includes bibliographical references (leaves 104-123). / Abstracts in English and Chinese. / Abstract --- p.i / Acknowledgements --- p.v / Publications --- p.vi / Table of contents --- p.viii / List of Figures --- p.xii / List of Tables --- p.xiv / Abbreviations --- p.xv / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Blood vessels and blood pressure --- p.1 / Chapter 1.2 --- Smooth muscle --- p.2 / Chapter 1.3 --- Endothelium --- p.3 / Chapter 1.4 --- Vasodilation and Vasoconstriction --- p.5 / Chapter 1.5 --- Calcitonin gene-related peptide (CGRP) --- p.6 / Chapter 1.5.1 --- Discovery of CGRP --- p.6 / Chapter 1.5.2 --- Localization and distribution of CGRP --- p.7 / Chapter 1.5.3 --- Structure profile of CGRP --- p.8 / Chapter 1.5.4 --- CGRP and the vascular system --- p.10 / Chapter 1.6 --- Nitric oxide --- p.11 / Chapter 1.6.1 --- Production of NO by nitric oxide synthase (NOS) --- p.12 / Chapter 1.6.2 --- Actions of NO in smooth muscle --- p.14 / Chapter 1.6.3 --- Synergism with CGRP --- p.14 / Chapter 1.7 --- Other research of CGRP in the laboratory of Professor Ronald R. Fiscus --- p.15 / Chapter 1.8 --- "Aging, diabetes mellitus, sex hormones and cardiovascular system" --- p.16 / Chapter 1.9 --- Aim of study --- p.18 / Chapter Chapter 2 --- Methods and materials --- p.19 / Chapter 2.1 --- General experimental methods --- p.19 / Chapter 2.1.1 --- Measurement of blood pressure in anaesthetized rats --- p.19 / Chapter 2.1.2 --- Tissue bath experiments --- p.20 / Chapter 2.1.2.1 --- Preparation of isolated rat aortic rings --- p.20 / Chapter 2.1.2.2 --- Measurement of contractile and relaxant responses in the rat aortic rings --- p.21 / Chapter 2.1.3 --- Culture of aortic rat vascular smooth muscle cells --- p.22 / Chapter 2.1.4 --- Immunostaining for smooth muscle α-actin in cultured smooth muscle cells --- p.23 / Chapter 2.1.5 --- Determination of nitrite levels in smooth muscle cell culture media --- p.24 / Chapter 2.1.6 --- Measurement of protein contents --- p.25 / Chapter 2.1.7 --- Reversed Transcription- Polymerase Chain Reaction (RT-PCR) --- p.26 / Chapter 2.1.7.1 --- mRNA isolation --- p.26 / Chapter 2.1.7.2 --- Reverse transcription (RT) --- p.27 / Chapter 2.1.7.3 --- Polymerase chain reaction (PCR) --- p.27 / Chapter 2.1.7.4 --- Agarose slab gel electrophoresis --- p.29 / Chapter 2.1.7.5 --- Capillary electrophoresis --- p.29 / Chapter 2.2 --- Reagents --- p.30 / Chapter Chapter 3 --- Impairment of hypotension to calcitonin gene-related peptide in female rats with streptozotocin-induced diabetes mellitus or ovariectomy --- p.40 / Chapter 3.1 --- Introduction --- p.40 / Chapter 3.2 --- Methods --- p.45 / Chapter 3.2.1 --- Animal Preparation --- p.45 / Chapter 3.2.2 --- Statistical analysis --- p.46 / Chapter 3.3 --- Results --- p.47 / Chapter 3.3.1 --- "Body weight, blood glucose and initial blood pressure" --- p.47 / Chapter 3.3.2 --- Hypotensive responses to CGRP in ovariectomized rats --- p.48 / Chapter 3.3.3 --- Hypotensive responses to CGRP in diabetic rats --- p.49 / Chapter 3.3.4 --- Hypotensive responses to CGRP in rats with diabetes and ovariectomy --- p.50 / Chapter 3.4 --- Discussion --- p.50 / Chapter 3.5 --- Conclusions --- p.56 / Chapter Chapter 4 --- Severe impairment of CGRP-induced hypotension in vivo and vasorelaxation in vitro in elderly rats --- p.61 / Chapter 4.1 --- Introduction --- p.61 / Chapter 4.2 --- Methods --- p.64 / Chapter 4.2.1 --- Tissue preparation for vascular rings --- p.64 / Chapter 4.2.2 --- Vasorelaxation studies in vitro --- p.65 / Chapter 4.2.3 --- Animal preparation for in vivo studies --- p.65 / Chapter 4.2.4 --- Measurement of hypotensive responses to CGRP --- p.66 / Chapter 4.2.5 --- Statistical analysis --- p.66 / Chapter 4.3 --- Results --- p.67 / Chapter 4.3.1 --- Effect of age on CGRP-induced vasorelaxations in rings of thoracic aorta and caudal arteries --- p.67 / Chapter 4.3.2 --- Effect of age on acetylcholine-induced responses in aortic rings --- p.68 / Chapter 4.3.3 --- CGRP-induced hypotension in young female and male rats --- p.68 / Chapter 4.3.4 --- CGRP-induced hypotension in elderly female and male rats --- p.68 / Chapter 4.3.5 --- CGRP-induced hypotension in elderly female rats with ovariectomy --- p.69 / Chapter 4.4 --- Discussion --- p.69 / Chapter 4.5 --- Conclusions --- p.73 / Chapter Chapter 5 --- "Effects of CGRP on interleukin-Iβ-, lipopolysaccharides- and ginseng extract-induced production of nitrite oxide in vascular smooth muscle cells of elderly rats" --- p.82 / Chapter 5.1 --- Introduction --- p.82 / Chapter 5.2 --- Methods --- p.83 / Chapter 5.2.1. --- Animal model --- p.83 / Chapter 5.2.2. --- Culture of vascular smooth muscle cells --- p.84 / Chapter 5.2.3 --- Extraction of total RNA --- p.84 / Chapter 5.2.4 --- Reverse transcription and polymerase chain reaction (RT-PCR) --- p.35 / Chapter 5.2.5 --- Capillary electrophoresis with laser-induced fluorescence detector (CE-LIF) --- p.85 / Chapter 5.2.6 --- Determination of nitrite levels in smooth muscle cell culture media --- p.85 / Chapter 5.2.7 --- Measurement of protein contents --- p.86 / Chapter 5.3 --- Results --- p.86 / Chapter 5.3.1 --- "Effects of IL-Iβ, alone and in combination with CGRP, on NO production in young and elderly VSMCs" --- p.86 / Chapter 5.3.2 --- "Effects of LPS, alone and in combination with CGRP, on NO production in young and elderly VSMCs" --- p.89 / Chapter 5.3.3 --- "Effects of ginseng extract, alone and in combination with CGRP, on NO production in VSMCs" --- p.89 / Chapter 5.4 --- Discussion --- p.90 / Chapter 5.5 --- Conclusions --- p.93 / Chapter Chapter 6 --- General discussion and Conclusions --- p.100 / References --- p.104
158

Avaliação da hemodinâmica cerebral através da técnica de ultrassonografia Doppler e suas correlações com as variações da pressão intracraniana em um modelo animal de hipertensão intracraniana / Evaluation of cerebral hemodynamics using the Doppler ultrasonography technique and its correlations with variations of intracranial pressure in an animal model of intracranial hypertension

Soares, Matheus Schmidt 28 March 2018 (has links)
Introdução: O aumento da pressão intracraniana (PIC) é um problema comum na prática neurocirúrgica, e a monitoração invasiva deste parâmetro faz parte da rotina de unidades de terapia intensiva. O Doppler transcraniano vem sendo testado na avaliação da hemodinâmica cerebral como parâmetro de avaliação não invasiva da PIC, porém há controvérsias na literatura sobre seu real benefício e utilidade nesta situação. Este estudo objetivou correlacionar os dados de avaliação do fluxo sanguíneo cerebral através da técnica de Doppler com as variações da monitoração invasiva da PIC na fase aguda de hipertensão intracraniana em um modelo animal. Métodos: Trata-se de um estudo experimental realizado em suínos. O experimento constou de dois grupos de animais (A e B) com hipertensão intracraniana gerada por insuflação com soro fisiológico de um balão no parênquima cerebral, sendo o grupo A com 4 mL e o grupo B com 7 mL. Nos dois grupos houve uma intervenção clínica com infusão de solução salina a 3% e uma simulação de intervenção cirúrgica (desinsuflação do balão). Em todos os momentos de insuflação do balão e das intervenções foram registrados os valores dos monitores de PIC e do Doppler: velocidades sistólica (VS), diastólica (VD), média (VM) do fluxo sanguíneo cerebral e índice de pulsatilidade (IP). Foram realizadas comparações do comportamento dos parâmetros avaliados pela ultrassonografia Doppler craniana (VS, VD, VM e IP) em relação às variações da PIC intraparenquimatosa. Resultados: Foram estudados 20 suínos sendo 10 no grupo A e 10 no grupo B. Um animal do grupo B foi excluído do estudo, pois foi a óbito antes do término do experimento. Após a insuflação do balão, como era de se esperar, a PIC no grupo B foi superior à do grupo A em todos os momentos, até a desinsuflação do mesmo. Realizada a correlação de Spearman observou-se correlação significativa entre IP e PIC, principalmente logo após insuflação do balão, ou seja, na elevação abrupta da PIC. Não houve correlação entre a PIC e os parâmetros VS, VD e VM. Também não houve variação significativa da PIC após infusão endovenosa de solução salina hipertônica. Conclusão: Este resultado demonstra o potencial do IP como bom parâmetro de avaliação de pacientes com suspeita de elevação hiperaguda e recente da PIC. Não se conseguiu demonstrar os mesmos resultados de correlação entre a PIC e as demais variáveis VS, VD e VM. Diante destes achados, adicionados aos dados conflitantes da literatura disponível até o momento, não se recomenda, por enquanto, a utilização desses parâmetros isoladamente como substitutos da monitoração invasiva da PIC, evidenciando a necessidade de mais estudos clínicos e experimentais / Introduction: Increased intracranial pressure (ICP) is a common problem in neurosurgical practice. Invasive monitoring of ICP in these cases is part of the intensive care unit routine. Transcranial Doppler has been tested in the evaluation of cerebral hemodynamics as a non-invasive evaluation of ICP, but there are controversies in the literature about its real benefit and usefulness in this situation. Thus, this study aimed to correlate the data of cerebral blood flow assessment using the Doppler technique and the invasive monitoring of ICP in the acute phase of intracranial hypertension in an animal model. Methods: This is an experimental study in pigs. During the experiment, an intracerebral expansive mass with an inflatable balloon was simulated. The experiment consisted of two groups (A and B) of animals with intracranial hypertension generated by a ballon inflation inside the cerebral parenchima, group A with 4 mL and group B with 7 mL. In both groups there was a clinical intervention with infusion of 3% saline solution and a simulation of surgical intervention (balloon drain out). The values of ICP and Doppler parameters (systolic (FVs), diastolic (FVd), and mean (FVm) cerebral blood flow velocities) were collected at all moments of balloon inflation and interventions, as well as the pulsatility index (PI). Comparisons of the behavior of the parameters evaluated by Doppler ultrasound (FVs, FVd, FVm and PI) were performed in relation to intraparenchymal ICP. Results: Twenty pigs were studied, 10 in group A and 10 in group B. One pig died in group B and it was excluded. After balloon inflation, as expected, ICP in group B was higher than in group A at all times, until the ballon was empty again. Significant correlation between PI and ICP was obtained when Spearman correlation was performed, mainly shortly after balloon inflation, that is, in the abrupt elevation of ICP. There was no correlation between ICP and FVs, FVd or FVm. There was also no significant change in ICP after intravenous infusion of hypertonic saline solution. Conclusion: These results demonstrate the potential of PI as a good parameter for the evaluation of patients with suspected ICP elevation. It was not possible to demonstrate the same correlation results between the ICP and FVs, FVd or FVm. Due to these results and also to the literature conflicting data to date, the use of these parameters alone as substitutes for the invasive monitoring of ICP is not recommended until now, which shows the need for further clinical and experimental studies
159

Avaliação do tratamento com um inibidor para serinoprotease em modelo experimental de enfisema induzido por exposição à fumaça de cigarro / Evaluation of a serine protease inhibitor treatment in an experimental model of cigarette smoke-induced emphysema

Juliana Dias Lourenço 07 April 2016 (has links)
Introdução: Demonstramos previamente que em modelo experimental de enfisema pulmonar induzido por instilação de elastase, o inibidor de serinoprotease rBmTI-A promoveu a melhora da destruição tecidual em camundongos. Considerando que o tabagismo é o principal fator de risco para o desenvolvimento da Doença Pulmonar Obstrutiva Crônica (DPOC) e que o modelo de exposição à fumaça de cigarro é considerado o que melhor mimetiza esta doença em humanos, este estudo teve por objetivo verificar a ação do inibidor para serinoproteases rBmTI-A sobre os processos fisiopatológicos envolvidos no desenvolvimento do enfisema pulmonar, em modelo de exposição ao tabaco. Métodos: Para a indução do enfisema pulmonar, os animais foram expostos à fumaça de cigarro (duas vezes ao dia/ 30 minutos/ 5 dias por semana/ durante 12 semanas), e os animais controle permaneceram expostos ao ar ambiente. Dois protocolos de tratamento com o inibidor rBmTI-A foram realizados. No primeiro, os animais receberam duas administrações do inibidor rBmTI-A ou de seu veículo (Solução Salina 0,9%) por via intranasal, sendo a primeira após 24h do término das exposições ao cigarro e outra, 7 dias após à primeira instilação do inibidor. No segundo protocolo, os animais receberam 3 administrações do inibidor rBmTI-A, durante o tempo de exposição (1ª dose: 24h antes do início da exposição à fumaça de cigarro; 2ª dose: um mês após o início da exposição; 3ª dose: dois meses após o início). Após o término dos protocolos de exposição e tratamento, os animais foram submetidos aos procedimentos para coleta dos dados de mecânica respiratória e avaliação do Intercepto Linear Médio (Lm). Para o segundo protocolo, realizamos também as medidas para quantificação de fibras de colágeno e elástica, da densidade de células positivas para MAC-2, MMP-12 e 9, TIMP-1, Gp91phox e TNFalfa; no parênquima através de imunohistoquímica, contagem de células polimorfonucleares além da expressão gênica de MMP-12 e 9 no pulmão através de RT-qPCR. Resultados e Discussão: O tratamento com o inibidor para serinoprotease rBmTI-A atenuou o desenvolvimento do enfisema pulmonar apenas no segundo protocolo, quando foi administrado durante a exposição à fumaça de cigarro. Embora os grupos Fumo-rBmTIA e Fumo-VE apresentem aumento de Lm comparados aos grupos controles, houve uma redução deste índice no grupo Fumo-rBmTIA comparado ao grupo Fumo-VE. O mesmo comportamento foi observado para as análises de proporção em volume de fibras de elástica e colágeno no parênquima. Além disto, observamos aumento de macrófagos, MMP-12, MMP-9 e TNFalfa; nos grupos expostos à fumaça de cigarro, mas o tratamento com o inibidor rBmTI-A diminuiu apenas a quantidade de células positivas para MMP-12. Na avaliação da expressão gênica para MMP-12 e 9, não observamos diferença entre os grupos experimentais e o mesmo comportamento foi observado para a quantidade de células polimorfonucleares no parênquima. Além disso, observamos aumento de GP91phox e TIMP-1 nos grupos tratados com rBmTIA. Conclusões: Tais resultados sugerem que o inibidor rBmTI-A não foi efetivo como tratamento da lesão após a doença instalada. Entretanto, atenuou o desenvolvimento da doença quando administrado durante a indução do enfisema, possivelmente através do aumento de GP91phox e TIMP-1, acompanhados pela diminuição de MMP-12. / Introduction: We have previously showed that in an elastase-induced model of emphysema, the treatment with a serine protease inhibitor rBmTI-A, resulted in an improvement of tissue destruction in mice. Considering that smoking is the main risk factor for the development of COPD, and the cigarette smoke (CS) exposure is considered the best model to reproduce physiopathologic similarities with such disease in humans, this study aimed to verify the rBmTI-A treatment on the physiopathological processes involved in the development of cigarette smoke-induced emphysema. Methods: To induce pulmonary emphysema, animals were exposed to cigarette smoke (twice a day/ 30 minutes/ 5 days per week/ for 12 weeks) and the control animals were exposed to room air. Two treatment protocols with rBmTI-A inhibitor were performed. In the first one, animals received two administrations of rBmTI-A inhibitor or its vehicle (Saline Solution 0.9%) by nasal instillation, one dose at 24 hours after the end of exposure to tobacco smoke and another one, 7 days after the first instillation of the inhibitor. In the second protocol, animals received 3 rBmTI-A inhibitor administrations during the exposition time (1st dose: 24 hours before the start of exposure to cigarette smoke; 2nd dose: one month after the start of exposure, 3rd dose: two months after the start). After the end of exposure and treatment protocols, animals were submitted to procedures for collection of respiratory mechanics and evaluation of the Mean Linear Intercept (Lm). For the second protocol, we also measured the volume proportion of collagen and elastic fibers, the density of positive cells for MAC-2, MMP-12 and -9, TIMP-1, GP91phox and TNF-alfa in lung parenchyma by immunohistochemistry. Also, we evaluated the measurement of polymorphonuclear cells and the lung gene expression for MMP-12 and 9 by RT-qPCR. Results and Discussion: Treatment with the serine protease inhibitor rBmTI-A attenuated the development of emphysema only in the second protocol, when it was administered during exposure to cigarette smoke. Although Smoke-rBmTIA and Smoke-VE groups showed an increase of Lm measure compared to Control groups, there were a decrease in the Smoke-rBmTIA group compared to Smoke-VE group. The same response was observed for the analysis of volume proportion of elastic and collagen fibers in parenchyma. In addition, we observed an increase of macrophages, MMP-12, MMP-9 and TNF-alfa; in groups exposed to cigarette smoke, but treatment with rBmTI-A inhibitor only decreased the number of positive cells for MMP-12. We did not observed difference between the experimental groups in lungs gene expression for MMP- 12 and 9, and the same behavior was observed for the amount of polymorphonuclear cells in parenchyma. Moreover, we observed an increase of GP91phox and TIMP-1 in groups treated with rBmTI-A. Conclusions: These results suggest that rBmTI-A inhibitor was not effective for treatment of parenchymal lesions after established disease. However, this inhibitor attenuated the development of disease when administered during the induction of emphysema, possibly by an increase of GP91phox and TIMP-1, accompanied by a decrease of MMP-12
160

Efeito do tratamento com PNU-282987, agonista do receptor colinérgico nicotínico alfa7, na resposta inflamatória e de remodelamento brônquico em modelo experimental de asma / Effects of PNU-282987 treatment, an agonist of ?7 nicotinic receptor, in inflammatory response and airway remodeling in an experimental model of asthma

Claúdia Jeane Claudino de Pontes Miranda 17 November 2016 (has links)
Introdução: A inflamação constitui um dos fatores mais importantes da fisiopatologia da asma brônquica, caracterizada por uma resposta eosinofílica com produção de citocinas de perfil Th2. A persistência desta inflamação induz no pulmão um processo de reparo associado à redução progressiva da função pulmonar, que nem sempre é revertida pelos tratamentos disponíveis. O sistema colinérgico anti-inflamatório é descrito como um mecanismo neural que suprime a resposta imune e controla a inflamação principalmente pelo efeito da acetilcolina em receptores nicotínicos do tipo alfa7 (alfa7nAChR) encontrados em células do sistema imune. A acetilcolina (ACh) exerce um importante efeito na asma e recentemente demonstramos que a redução parcial da liberação da acetilcolina induz per se a inflamação pulmonar. Embora se saiba que os receptores muscarínicos (mAChRs) exercem um efeito pró-inflamatório e broncoconstritor na asma, a ativação de receptores nicotínicos (nAChRs) poderia ter um efeito benéfico reduzindo a inflamação pulmonar, fato demonstrado em modelos de inflamação sistêmica e aguda. O efeito da ativação do alfa7nAChR na fisiopatologia da asma ainda não está claramente elucidado. Objetivo: Investigar o efeito do tratamento com PNU-282987 (PNU), um agonista específico do alfa7nAChR, em um modelo murino de inflamação alérgica crônica das vias aéreas. Metodologia: Camundongos BALB/c foram submetidos ao protocolo de indução alérgica crônica das vias aéreas com ovoalbumina (OVA) ou salina intraperitoneal (i.p.) e posterior desafios inalatórios. A partir do 22° dia, os animais receberam diariamente tratamento com PNU ou veículo (Ve) até o 28° dia. Foram testadas três doses de PNU (0,5, 1,0 e 2,0 mg/Kg). A fim de evidenciar se o efeito obtido no tratamento com PNU era dependente do receptor alfa7nAChR, um grupo de animais foi tratado com MLA (antagonista do alfa7nAChR), previamente ao tratamento com PNU. No 29° dia do protocolo, os animais foram eutanasiados e foram avaliados o número de células inflamatórias no lavado broncoalveolar (LBA) e no sangue, os níveis de citocinas no LBA, a expressão do alfa7nAChR e mAchRs do tipo 3 (M3) e a ativação do fator de transcrição nuclear kB (NF-kB) no pulmão. O remodelamento brônquico foi avaliado por morfometria. As análises estatísticas foram realizadas por meio do programa SigmaStat (Jandel Scientific, San Rafael, CA), onde um P < 0,05 foi considerado estatisticamente significativo. Resultados: Houve expressão do alfa7nAChR e M3 no homogenato de pulmão de animais controle e sensibilizados. Determinamos por meio da redução de eosinófilos que a dose de 0,5 mg/Kg do tratamento com PNU foi a mais efetiva. Assim, observamos que o tratamento com PNU0,5 nos animais sensibilizados reduziu o número de células totais, eosinófilos, neutrófilos, macrófagos e linfócitos no LBA, assim como número de eosinófilos no sangue periférico e ao redor das vias aéreas. O tratamento com PNU reduziu os níveis de IgE no sangue e as citocinas IL-4, IL-13 e IL-17 no LBA. Todos estes efeitos foram revertido com o pré-tratamento com MLA, exceto para a citocina IL-17. Alem disso, o tratamento com PNU reduziu o remodelamento brônquico (área de edema, de epitélio e de músculo liso e deposição de fibras colágenas) assim como o número de células positivas para MMP-9 e TIMP-1 ao redor das vias aéreas. No pulmão a expressão do p-65-NF-kB, STAT3 fosforilado e o SOCS3 foram inibidas pelo PNU. Conclusão: Estes dados claramente demonstram que o alfa7nAChR está envolvido no controle da resposta inflamatória pulmonar alérgica e de remodelamento brônquico em modelo experimental de asma alérgica e portanto é um novo alvo com potencial terapêutico a ser explorado na fisiopatologia da asma brônquica / Background: Inflammation is one of the most important features in asthma pathophysiology, characterized by eosinophilic response with production of Th2 cytokine profile. The persistence of this inflammation can induce a lung repair process associated with a progressive reduction in lung function, which is not always reversed by available treatments. The anti-inflammatory cholinergic system was described as a neural mechanism that suppresses the immune response and controls inflammation mainly by the activaction of acetylcholine alfa7 nicotinic receptors (alfa7nAChR) found on immune cells. Acetylcholine (ACh) is an important mediator in asthma and we recently demonstrated that partial reduction on ACh release induced lung inflammation per se. Although it is known that muscarinic receptors (mAChRs) has a pro-inflammatory action and causes bronchoconstriction in asthma, the activation of nicotinic receptors (nAChRs) could have a beneficial effect reducing pulmonary inflammation as demonstrated in models of acute and systemic inflammation. The effects of alfa7nAChR activation in the pathophysiology of asthma have not been clearly elucidated. Aim: To investigate the effects of PNU- 282987 (PNU) treatment, a specific alfa7nAChR agonist, in a murine model of chronic allergic airway inflammation. Methods: BALB/c mice were subjected to a protocol of chronic allergic inflammation induced by intraperitoneal ovalbumin (OVA) or saline and subsequent challenges with inhalation. From the 22th day, the animals daily received PNU or vehicle (Ve) until the 28th day. PNU were tested in three differents doses (0.5, 1.0 and 2.0 mg/kg). In order to demonstrate that the effects obtained by PNU treatment was dependent on alfa7nAChR, a group of animals was treated with MLA (antagonist of alfa7nAChR) prior to the PNU treatment. On the 29th day of the protocol, the animals were euthanised and the number of inflammatory cells in the bronchoalveolar lavage fluid(BALF) fluid and blood, cytokine levels in BALF, the expression of alfa7nAChR and mAChRs type 3 (M3), and activation of nuclear transcription factor kB (NF-kB) in the lung were evaluated. Bronchial remodeling was assessed by morfometric methods. Statistical analyses were performed using the SigmaStat (Jandel Scientific, San Rafael, CA) and P < 0.05 is considered statistically significant. Results: ?7nAChR and M3 expression was detected in control and sensitized lung homogenate. The most effective dose of PNU treatment was 0.5 mg/kg evaluated by the effects on eosinophil reduction. Thus, we observed that treatment with PNU0,5 reduced the number of total cells, eosinophils, neutrophils, macrophages and lymphocytes in BALF, as well as number of eosinophils in peripheral blood and around the airways of sensitized animals. The treatment with PNU also reduced IgE levels in the blood, and cytokines IL-4, IL-13 and IL-17 in BALF. All these effects were reversed by pretreatment with MLA, except for IL-17 cytokine. Furthermore, treatment with PNU reduced bronchial remodeling (edema, epithelium and smooth muscle area and airway collagen deposition) as well as the number of positive cells for MMP-9 and TIMP-1 around the airways. The lung p-65-NF-kB, phosphorylated STAT3 and the SOCS3 expression were inhibited by PNU-282987. Conclusion: These data clearly demonstrate that the alfa7nAChR is involved in the control of allergic pulmonary inflammatory response and in bronchial remodeling in an experimental model of allergic asthma and it can be a new target with therapeutic potential to be explored in the pathophysiology of asthma

Page generated in 0.0515 seconds